BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30693469)

  • 1. Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses.
    Chacón-Solano E; León C; Díaz F; García-García F; García M; Escámez MJ; Guerrero-Aspizua S; Conti CJ; Mencía Á; Martínez-Santamaría L; Llames S; Pévida M; Carbonell-Caballero J; Puig-Butillé JA; Maseda R; Puig S; de Lucas R; Baselga E; Larcher F; Dopazo J; Del Río M
    Br J Dermatol; 2019 Sep; 181(3):512-522. PubMed ID: 30693469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
    Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
    Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
    Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts.
    Atanasova VS; Russell RJ; Webster TG; Cao Q; Agarwal P; Lim YZ; Krishnan S; Fuentes I; Guttmann-Gruber C; McGrath JA; Salas-Alanis JC; Fertala A; South AP
    J Invest Dermatol; 2019 Jul; 139(7):1497-1505.e5. PubMed ID: 30684555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of senescence pathways in Kindler syndrome primary keratinocytes.
    Piccinni E; Di Zenzo G; Maurelli R; Dellambra E; Teson M; Has C; Zambruno G; Castiglia D
    Br J Dermatol; 2013 May; 168(5):1019-26. PubMed ID: 23278235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pathogenic FERMT1 variant in four families with Kindler syndrome in Argentina.
    Valinotto LE; Natale MI; Lusso SB; Cella E; Gutiérrez O; Sebastiani F; Manzur GB
    Pediatr Dermatol; 2020 Mar; 37(2):337-341. PubMed ID: 31957900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
    Aguado T; García M; García A; Ferrer-Mayorga G; Martínez-Santamaría L; Del Río M; Botella LM; Sánchez-Puelles JM
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is adermatoglyphia an additional feature of Kindler Syndrome?
    Almeida HL; Goetze FM; Fong K; Lai-Cheong J; McGrath J
    An Bras Dermatol; 2015; 90(4):592-3. PubMed ID: 26375235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of Kindler syndrome and propensity for skin cancer - case report and literature review.
    Saleva M; Has C; He Y; Vassileva S; Balabanova M; Miteva L
    J Dtsch Dermatol Ges; 2018 Mar; 16(3):338-341. PubMed ID: 29384271
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of Kindler syndrome in a young Indian female with exon deletion.
    Fukushi R; Tsuboi R; Maeda T; Kanda Y; Sakai N; Suzuki S; Harada K
    Int J Dermatol; 2019 Jan; 58(1):e19-e21. PubMed ID: 30414177
    [No Abstract]   [Full Text] [Related]  

  • 11. Sporadic Kindler syndrome with a novel mutation.
    Almeida HL; Heckler GT; Fong K; Lai-Cheong J; McGrath J
    An Bras Dermatol; 2013; 88(6 Suppl 1):212-5. PubMed ID: 24346923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome.
    Maier K; He Y; Wölfle U; Esser PR; Brummer T; Schempp C; Bruckner-Tuderman L; Has C
    Hum Mol Genet; 2016 Dec; 25(24):5339-5352. PubMed ID: 27798104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
    Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of Mechanisms Underlying Latent TGF-β Activation in Recessive Dystrophic Epidermolysis Bullosa.
    Akasaka E; Kleiser S; Sengle G; Bruckner-Tuderman L; Nyström A
    J Invest Dermatol; 2021 Jun; 141(6):1450-1460.e9. PubMed ID: 33333127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
    Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
    Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial loss of epithelial phenotype in kindlin-1-deficient keratinocytes.
    Qu H; Wen T; Pesch M; Aumailley M
    Am J Pathol; 2012 Apr; 180(4):1581-92. PubMed ID: 22326752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and treatment of the newborn with epidermolysis bullosa.
    Gonzalez ME
    Semin Perinatol; 2013 Feb; 37(1):32-9. PubMed ID: 23419761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis.
    Chacón-Solano E; León C; Carretero M; García M; Sánchez-Domínguez R; Quero F; Méndez-Jiménez E; Bonafont J; Ruiz-Mezcua B; Escámez MJ; Larcher F; Del Río M
    Matrix Biol; 2022 Aug; 111():189-206. PubMed ID: 35779740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.
    Beilin AK; Evtushenko NA; Lukyanov DK; Murashkin NN; Ambarchian ET; Pushkov AA; Savostyanov KV; Fisenko AP; Rogovaya OS; Vasiliev AV; Vorotelyak EA; Gurskaya NG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.